Listeria-based booster improves vaccine's protection against recurring colon cancer - Science Daily

New research in mice has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.

Colorectal, pancreatic, esophageal and stomach cancers -- some of the deadliest kinds of cancer -- have high recurrence rates where the cancer comes back even after successful surgery or radiation tr… [+3883 chars]

full article...